Press Releases
Optibrium secures multi-million-pound financing package from Shawbrook to accelerate...
Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology.
CAMBRIDGE, UK, 08 July 2025 – Optibrium, a...
Press Releases
Aptar CSP Technologies’ Dual-Active Material Science Technology Simultaneously Controls...
Dual-active material science solution is ideal for sensitive formulations
Auburn, AL, July 8, 2025 – Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in...
Press Releases
datma Launches Federated Biomarker Explorer with Free Access to...
Pharma teams can now assess biomarker coverage across datma's federated network with no cost, contracts, or IT support required.
datma, a leader in federated real-world data...
Press Releases
Infudopa SubC Parkinsons Therapy: Neuraxpharm-Dizlin Deal
Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company dedicated to central nervous system (CNS) disorders, and Dizlin Pharmaceuticals AB (“Dizlin”), a Swedish R&D company...
Press Releases
HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER
Haleon today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025.
This appointment follows Franck...
Drug Research
Hikma Pharmaceuticals USA announces $1 Billion of new US...
London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it...
Press Releases
API China 2025 Concludes with Strong Turnout and Industry-Wide...
Asia’s leading pharma show draws 200,000 visits and nearly 4,000 exhibitors across three co-located events in Guangzhou
Beijing, The 92nd edition of API China successfully wrapped up on 23...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.